Page last updated: 2024-12-08
da 5018
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
DA 5018: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 177286 |
| MeSH ID | M0266866 |
Synonyms (16)
| Synonym |
|---|
| da-5018 |
| capsavanil |
| benzeneacetamide, 4-(2-aminoethoxy)-n-(3-(3,4-dimethylphenyl)propyl)-3-methoxy-, monohydrochloride |
| da 5018 |
| n-(3-(3,4-dimethylphenyl)propyl)-4-(2-aminoethoxy)-3-methoxyphenyl acetamide |
| davasaicin hydrochloride |
| unii-51v6n8ba2p |
| 51v6n8ba2p , |
| 174661-97-3 |
| benzeneacetamide, 4-(2-aminoethoxy)-n-(3-(3,4-dimethylphenyl)propyl)-3-methoxy-, hydrochloride (1:1) |
| DTXSID40169887 |
| Q27260923 |
| 2-(4-(2-aminoethoxy)-3-methoxyphenyl)-n-(3-(3,4-dimethylphenyl)propyl)acetamide hydrochloride |
| 2-[4-(2-aminoethoxy)-3-methoxyphenyl]-n-[3-(3,4-dimethylphenyl)propyl]acetamide;hydrochloride |
| benzeneacetamide, 4-(2-aminoethoxy)-n-[3-(3,4-dimethylphenyl)propyl]-3-methoxy-, hydrochloride (1:1) |
| AKOS040745705 |
Research Excerpts
Pharmacokinetics
| Excerpt | Reference | Relevance |
|---|---|---|
| " administration of DA-5018, 1, 2, and 5 mg kg-1, the pharmacokinetic parameters of DA-5018 were independent of the dose ranges studied." | ( Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats. Kim, SH; Kim, WB; Lee, JJ; Lee, MG; Lee, SD; Shim, HJ; Yang, J, 1998) | 0.3 |
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| " After oral administration of DA-5018, absorption of the drug from gastrointestinal (GI) tract was fast, but the extent of absolute bioavailability (F) was low; the values were 23." | ( Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats. Kim, SH; Kim, WB; Lee, JJ; Lee, MG; Lee, SD; Shim, HJ; Yang, J, 1998) | 0.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 23.93
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.93) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||